Stocktoria
NEUROCRINE BIOSCIENCES INC NBIX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1996-05-23
NEUROCRINE BIOSCIENCES INC institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 14,190,708 | $2.0B |
| DODGE & COX | 5,461,037 | $719.4M |
| AQR CAPITAL MANAGEMENT LLC | 4,938,967 | $650.7M |
| TWO SIGMA INVESTMENTS, LP | 3,060,570 | $403.2M |
| RENAISSANCE TECHNOLOGIES LLC | 2,418,897 | $318.7M |
| MILLENNIUM MANAGEMENT LLC | 1,247,447 | $164.3M |
| Bridgewater Associates, LP | 148,141 | $19.5M |
| D. E. Shaw & Co., Inc. | 89,184 | $11.7M |
Source: SEC EDGAR filings · CIK 0000914475 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.